Transjugular Intrahepatic Portosystemic Shunts in Patients with Hepatic Malignancy

Michael J. Wallace; David C. Madoff

doi:10.1055/s-2005-925557

Seminars in Interventional Radiology, Table of Contents

Semin intervent Radiol 2005; 22(4): 309-315
DOI: 10.1055/s-2005-925557

Transjugular Intrahepatic Portosystemic Shunts in Patients with Hepatic Malignancy

Michael J. Wallace¹ , David C. Madoff¹

¹Department of Diagnostic Radiology, Section of Interventional Radiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Abstract

ABSTRACT

Since its first clinical application in 1988, the transjugular intrahepatic portosystemic shunt (TIPS) has emerged as a safe and effective means of managing patients with morbid portal hypertension. Despite the considerable body of literature on TIPS, portal decompression in patients with malignancy has not been sufficiently examined. These patients typically experience sequelae of portal hypertension that requires palliation. The purpose of this article is to review the reported experience with TIPS in patients with malignancy.

KEYWORDS

Hepatic neoplasm - interventional procedure - portosystemic shunt - portal hypertension

Full Text

References

REFERENCES

1 Cello J P, Ring E J, Olcott E W et al.. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage: a randomized, controlled trial. Ann Intern Med. 1997; 126 858-865
2 Rossle M, Deibert P, Haag K et al.. Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding. Lancet. 1997; 349 1043-1049
3 Pomier-Layrargues G, Villeneuve J P, Deschenes M et al.. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut. 2001; 48 390-396
4 Rossle M, Ochs A, Gulberg V et al.. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med. 2000; 342 1701-1707
5 Gordon F D, Anastopoulos H T, Crenshaw W et al.. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt. Hepatology. 1997; 25 1366-1369
6 Siegerstetter V, Deibert P, Ochs A, Olschewski M, Blum H E, Rossle M. Treatment of refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt: long-term results in 40 patients. Eur J Gastroenterol Hepatol. 2001; 13 529-534
7 Perello A, Garcia-Pagan J C, Gilabert R et al.. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology. 2002; 35 132-139
8 Blum U, Rossle M, Haag K et al.. Budd-Chiari syndrome: technical, hemodynamic, and clinical results of treatment with transjugular intrahepatic portosystemic shunt. Radiology. 1995; 197 805-811
9 Haskal Z J, Martin L, Cardella J F et al.. Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. SCVIR Standards of Practice Committee. J Vasc Interv Radiol. 2001; 12 131-136
10 Nakamura K, Hamuro M, Nishida N, Kaminou T, Satoh K, Matsuoka T. Hepatocellular Carcinoma and Portal Hypertension: Indication for Transjugular Intrahepatic Portosystemic Shunt. Chicago, IL; Radiological Society of North America 2002
11 Sakaguchi H, Uchida H, Maeda M et al.. Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report. Cardiovasc Intervent Radiol. 1995; 18 9-15
12 Wallace M J, Madoff D C, Ahrar K, Warneke C L. Transjugular intrahepatic portosystemic shunts: experience in the oncology setting. Cancer. 2004; 101 337-345
13 Azoulay D, Buabse F, Damiano I et al.. Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg. 2001; 193 46-51
14 Zuckerman D A, Darcy M D, Bocchini T P, Hildebolt C F. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol. 1997; 169 1727-1731
15 LaBerge J M, Ring E J, Gordon R L et al.. Creation of transjugular intrahepatic portosystemic shunts with the wallstent endoprosthesis: results in 100 patients. Radiology. 1993; 187 413-420
16 Hidajat N, Vogl T, Stobbe H et al.. Transjugular intrahepatic portosystemic shunt: experiences at a liver transplantation center. Acta Radiol. 2000; 41 474-478
17 Malinchoc M, Kamath P S, Gordon F D, Peine C J, Rank J, ter Borg P C. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000; 31 864-871
18 Barton R E, Rosch J, Saxon R R, Lakin P C, Petersen B D, Keller F S. TIPS-short and long-term results: a survey of 1750 patients. Semin Intervent Radiol. 1995; 12 364-367
19 Jiang Z B, Shan H, Shen X Y et al.. Transjugular intrahepatic portosystemic shunt for palliative treatment of portal hypertension secondary to portal vein tumor thrombosis. World J Gastroenterol. 2004; 10 1881-1884
20 Otal P, Smayra T, Bureau C et al.. Preliminary results of a new expanded-polytetrafluoroethylene-covered stent-graft for transjugular intrahepatic portosystemic shunt procedures. AJR Am J Roentgenol. 2002; 178 141-147
21 Hur J, Lee K H, Lee J H, Yu J S, Won J Y, Lee D Y. Stent-graft for TIPS in a hepatocellular carcinoma patient with main portal vein invasion. AJR Am J Roentgenol. 2004; 182 1301-1304
22 Petersen B. Intravascular ultrasound-guided direct intrahepatic portacaval shunt: description of technique and technical refinements. J Vasc Interv Radiol. 2003; 14 21-32
23 Soares G M, Murphy T P. Transcaval TIPS: indications and anatomic considerations. J Vasc Interv Radiol. 1999; 10 1233-1238
24 Walser E M, NcNees S W, DeLa Pena O et al.. Portal venous thrombosis: percutaneous therapy and outcome. J Vasc Interv Radiol. 1998; 9 119-127
25 Radosevich P M, Ring E J, LaBerge J M et al.. Transjugular intrahepatic portosystemic shunts in patients with portal vein occlusion. Radiology. 1993; 186 523-527
26 Matsui O, Yoshikawa J, Kadoya M et al.. Transjugular intrahepatic portosystemic shunt after previous recanalization of a chronically thrombosed portal vein via a transmesenteric approach. Cardiovasc Intervent Radiol. 1996; 19 352-355
27 Yamagami T, Nakamura T, Tanaka O, Akada W, Takayama T, Maeda T. Transjugular intrahepatic portosystemic shunt after complete obstruction of portal vein. J Vasc Interv Radiol. 1999; 10 575-578
28 Jalan R, Lui H F, Redhead D N, Hayes P C. TIPSS 10 years on. Gut. 2000; 46 578-581
29 Saxon R S, Ross P L, Mendel-Hartvig J et al.. Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms. Radiology. 1998; 207 683-693
30 Wallace M, Swaim M. Transjugular intrahepatic portosystemic shunts through hepatic neoplasms. J Vasc Interv Radiol. 2003; 14 501-507
31 Saxon R R, Mendel-Hartvig J, Corless C L et al.. Bile duct injury as a major cause of stenosis and occlusion in transjugular intrahepatic portosystemic shunts: comparative histopathologic analysis in humans and swine. J Vasc Interv Radiol. 1996; 7 487-497
32 Hausegger K A, Karnel F, Georgieva B et al.. Transjugular intrahepatic portosystemic shunt creation with the Viatorr expanded polytetrafluoroethylene-covered stent-graft. J Vasc Interv Radiol. 2004; 15 239-248
33 Encarnacion C E, Palmaz J C, Rivera F J et al.. Transjugular intrahepatic portosystemic shunt placement for variceal bleeding: predictors of mortality. J Vasc Interv Radiol. 1995; 6 687-694
34 Coldwell D M, Ring E J, Rees C R et al.. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension. Radiology. 1995; 196 335-340
35 Gines P, Uriz J, Calahorra B et al.. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology. 2002; 123 1839-1847
36 Ferral H, Vasan R, Speeg K V et al.. Evaluation of a model to predict poor survival in patients undergoing elective TIPS procedures. J Vasc Interv Radiol. 2002; 13 1103-1108
37 Angermayr B, Cejna M, Karnel F et al.. Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut. 2003; 52 879-885

Michael J WallaceM.D.

Department of Diagnostic Radiology, Section of Interventional Radiology, Unit 325

The University of Texas M.D. Anderson Cancer Center

1515 Holcombe Boulevard, Houston, TX 77030-4009